Obesity has reached epidemic proportions in the US. Estimates show that nearly half of all Americans will have obesity by 2030, including 1 in 4 who will have severe obesity. Those numbers carry big implications for Americans’ health — and healthcare costs. The US already spends over a trillion dollars on obesity-related complications every year, and that amount will only grow if we continue down this path.
Employers, health plans, and their partners are considering various strategies to get a handle on obesity and curb cost trends. Some hope that new GLP-1 medications can solve the obesity crisis; others want to shut off access to the pricey drugs completely. Even more folks sit somewhere in between. Watch the on-demand webinar to learn:
- Five common myths of obesity management
- Key facts about GLP-1s and other anti-obesity medications
- How you can take action this year before obesity expenses completely fall off the rails
Featured speakers
Jennifer Frangos, DO
Senior Medical Director at Vida
Kevin Knight
Chief Marketing Officer
at Vida
Gretchen Zimmermann
VP of Clinical Strategy
at Vida
A Guide to Obesity Step Therapy
How can obesity step therapy help your organization?